FishGastro Study: Fish Consumption and Gastro-Intestinal Health

NCT ID: NCT00145015

Last Updated: 2008-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

270 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-12-31

Study Completion Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether increasing the dietary intake of n-3 fatty acids by the consumption of oil-rich fish reduces the risk of developing colorectal cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Epidemiological evidence from several countries supports a protective effect of fish consumption on cancer risk and gastrointestinal cancers in particular. Further evidence to support the idea that fish consumption is protective in relation to cancers of the GI tract is now emerging from the European Investigation into Cancer and Nutrition (EPIC).

The FISHGASTRO project is headed by the Institute of Food Research and includes groups from the University of East Anglia, the University of Wageningen, Netherlands and the University of Jena, Germany. The project focuses on assessing the impact of fish consumption on a range of markers of gastrointestinal health associated with ulcerative colitis or colon cancer and on looking at bio-accessibility of a range of nutrients from fish. We aim to recruit a total of 270 patients with gastrointestinal problems in the UK and Netherlands and take biopsy and blood samples before and after asking them to eat two extra portions of fish per week. One group will receive oil rich fish such as salmon while another will be asked to eat white fish. Changes in cell proliferation, apoptosis, inflammatory markers, gene expression and plasma levels of n-3 fatty acids will be compared to a control group only given standard nutritional advice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Ulcerative Colitis Polyps

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Intervention Adults Colorectal cancer Nutrition Fish n-3 fatty acids Apoptosis Ulcerative colitis Polyps Gastro-intestinal tract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Increased dietary intake of salmon or cod

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Ulcerative Colitis Patient Group (Group 1):

* Aged 18 - 80
* Male or female
* Diagnosed with ulcerative colitis
* Attending gastroenterology clinic for routine colonoscopy check-up
* Willing to increase dietary intake of fish for six months
* Willing to undergo a flexible sigmoidoscopy examination

Polyps/Resection Group (Group 2):

* Aged 18 - 80
* Male or female
* A history of polyps in the colon
* Attending gastroenterology clinic for routine colonoscopy check-up
* Willing to increase dietary intake of fish for six months
* Willing to undergo a flexible sigmoidoscopy examination

Control Group (Group 3):

* Aged 18 - 80
* Male or female
* Booked for a colonoscopy examination for the investigation of iron deficiency anaemia of unknown cause (no evidence of macroscopic disease found during examination)
* Willing to increase dietary intake of fish for six months
* Willing to undergo a flexible sigmoidoscopy examination

Exclusion Criteria

Ulcerative Colitis Patient Group (Group 1) and Polyps/Resection Group (Group 2):

* Allergic to fish
* Receiving anticoagulant therapy
* Diabetics
* Pregnant or breast-feeding
* Organ transplant recipients receiving immunosuppression therapy
* Prosthetic heart valve
* Allergic to pethidine
* Previous diagnosis of bacterial endocarditis

Control Group (Group 3):

Same as Groups 1 and 2 plus:

* Received a diagnosis of colorectal cancer following initial investigative colonoscopy (volunteer will be withdrawn from the study when diagnosed as requiring treatment)
* Received a diagnosis of coeliac disease following initial investigative colonoscopy (volunteer will be withdrawn from the study when diagnosed as requiring a modified diet)
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wageningen University

OTHER

Sponsor Role collaborator

University of Jena

OTHER

Sponsor Role collaborator

University of East Anglia

OTHER

Sponsor Role collaborator

European Commission

OTHER

Sponsor Role collaborator

Food Standards Agency, United Kingdom

OTHER_GOV

Sponsor Role collaborator

Quadram Institute Bioscience

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elizabeth K Lund, PhD

Role: PRINCIPAL_INVESTIGATOR

Quadram Institute Bioscience

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wageningen

Wageningen, , Netherlands

Site Status

Institute of Food Research

Norwich, Norfolk, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Pot GK, Geelen A, Majsak-Newman G, Harvey LJ, Nagengast FM, Witteman BJ, van de Meeberg PC, Hart AR, Schaafsma G, Lund EK, Rijkers GT, Kampman E. Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies. J Nutr. 2010 Feb;140(2):371-6. doi: 10.3945/jn.109.113472. Epub 2009 Dec 23.

Reference Type DERIVED
PMID: 20032491 (View on PubMed)

Pot GK, Majsak-Newman G, Geelen A, Harvey LJ, Nagengast FM, Witteman BJ, van de Meeberg PC, Timmer R, Tan A, Wahab PJ, Hart AR, Williams MP, Przybylska-Phillips K, Dainty JR, Schaafsma G, Kampman E, Lund EK; FISHGASTRO Study Group. Fish consumption and markers of colorectal cancer risk: a multicenter randomized controlled trial. Am J Clin Nutr. 2009 Aug;90(2):354-61. doi: 10.3945/ajcn.2009.27630. Epub 2009 Jun 24.

Reference Type DERIVED
PMID: 19553301 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IFR02/2004

Identifier Type: -

Identifier Source: org_study_id